Mirae Asset Global Investments
CAI icon

Mirae Asset Global Investments’s Caris Life Sciences CAI Stock Holding History

Mirae Asset Global Investments’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225K Sell
12,643
-2,074
-14% -$37.1K ﹤0.01% 1103
2026
Q1 		$263K Buy
14,717
+1,006
+7% +$22K ﹤0.01% 1034
2025
Q4 		$370K Buy
+13,711
New +$386K ﹤0.01% 1050

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PointState Capital
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Mirae Asset Global Investments's CAI Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Caris Life Sciences (CAI) stake by 14% in Q2 2026, selling an estimated $37.1K and leaving 12,643 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #1103.

Mirae Asset Global Investments first reported a position in CAI in Q4 2025 and has held it in 3 quarters since. The position peaked at $370K in Q4 2025. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Mirae Asset Global Investments held 12,643 shares of Caris Life Sciences worth $225K as of Q2 2026.
  • Mirae Asset Global Investments sold 2,074 Caris Life Sciences shares in Q2 2026, an estimated $37.1K.
  • Caris Life Sciences made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1103 holding.
  • Mirae Asset Global Investments first reported a position in Caris Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • Mirae Asset Global Investments's Caris Life Sciences position peaked at $370K in Q4 2025.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.